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Available online 21 February 2008SP-C, the smallest pulmonary surfactant protein, is required for the formation and stability of surface-active ﬁlms
at the air–liquid interface in the lung. Theprotein consists of a hydrophobic transmembraneα-helix and a cationic
N-terminal segment containingpalmitoylated cysteines. Recent evidence suggests that theN-terminal segment is
of critical importance for SP-C function. In the present work, the role of palmitoylation in modulating the lipid–
protein interactions of the N-terminal segment of SP-C has been studied by analyzing the effect of palmitoylated
and non-palmitoylated synthetic peptides designed tomimic the N-terminal segment on the dynamic properties
of phospholipid bilayers, recorded by spin-label electron spin resonance (ESR) spectroscopy. Both palmitoylated
andnon-palmitoylatedpeptides decrease themobility of phosphatidylcholine (5-PCSL) and phosphatidylglycerol
(5-PGSL) spin probes in dipalmitoylphosphatidylcholine (DPPC) or dipalmitoylphosphatidylglycerol (DPPG)
bilayers. In zwitterionic DPPCmembranes, both peptides have a greater effect at temperatures below than above
themain gel-to-liquid-crystalline phase transition, the palmitoylated peptide inducing greater immobilisation of
the lipid than does the non-palmitoylated form. In anionic DPPG membranes, both palmitoylated and non-
palmitoylated peptides have similar immobilizing effects, probably dominated by electrostatic interactions. Both
palmitoylated and non-palmitoylated peptides have effects comparable to whole native SP-C, as regards
improving the gel phase solubility of phospholipid spin probes and increasing the polarity of the bilayer surface
monitored by pK shifts of fatty acid spin probes. This indicates that a signiﬁcant part of the perturbing properties
of SP-C in phospholipid bilayers is mediated by interactions of the N-terminal segment. The effect of
SP-C N-terminal peptides on the chain ﬂexibility gradient of DPPC and DPPG bilayers is consistent with the
existence of a peptide-promoted interdigitated phase at temperatures below the main gel-to-liquid-crystalline
phase transition. The palmitoylated peptide, but not the non-palmitoylated version, is able to stably segregate
interdigitated and non-interdigitated populations of phospholipids in DPPC bilayers. This feature suggests that
the palmitoylated N-terminal segment stabilizes ordered domains such as those containing interdigitated lipids.
We propose that palmitoylation may be important to promote and facilitate association of SP-C and SP-C-
containing membranes with ordered lipid structures such as those potentially existing in highly compressed
states of the interfacial surfactant ﬁlm.







S-acylation of cysteine residues in proteins is decisive to function,
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ll rights reserved.brane, and it additionally modulates lipid–protein interactions [1].
Palmitoylation of proteins with only one transmembrane domain
usually occurs juxtaposed with the transmembrane region, as is the
case with the pulmonary surfactant protein SP-C [2].
SP-C is not strictly required to initiate respiratory function at birth,
as shown by survival of SP-C knock-out mice [3]. However, the lungs of
these SP-C-deﬁcient animals appear to be intrinsically unstable.
Consistent with this, genetic deﬁciencies in the structure and expres-
sion of the SP-C gene have been found in patients developing chronic
respiratory diseases [4]. In vitro, SP-C has been shown to promote
interfacial phospholipid adsorption and to stabilize interfacial mono-
layers that are subjected to dynamic compression–expansion cycling
[5,6]. SP-C seems also to participate in generating the surface-attached
reservoir of surfactant that provides a continuous supply of surface-
active molecules to replenish the interfacial ﬁlm during successive
Fig. 1. ESR spectra of a 5-PCSL spin-label in dipalmitoylphosphatidylcholine (DPPC) bilayers, in the presence or in the absence (dashed line) of 40 wt% of the acylated peptide pSP-C
(Palm)2 (solid black line) or the non-palmitoylated peptide pSP-C(free) (solid grey line), at the temperatures indicated. Lines connecting the different spectra are visual guides to
illustrate temperature-dependent reduction in the total spectral width. The total scan range was 100 G. Inserts on the left- and right-hand sides show expanded details of the low-
and high-ﬁeld peaks of the ESR spectra in the absence (dashed line) or presence (solid line) of the palmitoylated or non-palmitoylated peptide, as indicated.
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or two cysteines at the N-terminal region, including the very recently
reported SP-C sequence from the toad Xenopus [8–10], and in all cases
investigated these N-terminal cysteines are stoichiometrically palmi-
toylated. Numerous biophysical studies of SP-C have indicated that
palmitoylation of the N-terminal region increases hydrophobicity,
which is important for stabilization of the α-helical structure [11,12],
favoring the interaction of the protein with surfactant phospholipids.
Moreover, palmitoylation plays an important role in the correct
adsorption and reincorporation of surfactant material into the sur-
face-active ﬁlm [13,14], and in the stability of these ﬁlms when sub-
jected to repetitive compression–expansion cycling [15]. In contrast,
other studies did not ﬁnd signiﬁcant differences when comparing the
behaviour of acylated and deacylated forms of SP-C in interfacial ﬁlms
[16,17]. On the other hand, non-palmitoylated recombinant forms of
SP-C produced in bacteria show similar, if not better, ability to promote
formation of phospholipid-based interfacial ﬁlms than does the native
palmitoylated protein puriﬁed from mammalian lungs [18]. In the
same direction, surfactant preparations containing non-palmitoylated
recombinant SP-C forms as the only protein component have shown
efﬁciency in restoring pulmonary function in vivo [19–21].
In recent years, studies with synthetic peptides mimicking the
sequence of the N-terminal segment of SP-C have shown that this
region of the protein possesses intrinsic capability to interact with and
to perturb phospholipid bilayers [22] andmonolayers [23], even in the
absence of palmitoylation. The question is, therefore, how palmitoyla-
tion modulates the conformation and/or the manner in which the N-
terminal segment interacts with phospholipids. Palmitoylation of the
SP-C N-terminal segment, for instance, seems to be important in
maintaining the association of this protein segment with highly
compressed interfacialﬁlms [24,25], such as those formed at the end of
exhalation during respiration. Whether association with compressed
states requires a particular conformation or disposition of the
palmitoylated segment in the lipid layers, or is maintained exclusively
through the interfacial insertion of the protein acyl chains, is not clear.
A major objective of the present work is to obtain further insight into
the effect of palmitoylation on the mode and extent of lipid–protein
interactions established by the N-terminal segment of SP-C in phos-pholipid bilayers, by using spin-label electron spin resonance (ESR)
spectroscopy.
2. Materials and methods
2.1. Materials
Chloroform (Chl) and methanol (MeOH) were HPLC-grade solvents from Scharlau
(Barcelona, Spain). The lipids, dipalmitoylphosphatidylcholine (DPPC) and dipalmi-
toylphosphatidylglycerol (DPPG), were purchased from Avanti Polar Lipids (Birming-
ham, AL, USA). Spin-labelled phosphatidylcholine and phosphatidylglycerol with the
nitroxide group at different positions in the sn-2 acyl chain were synthesized as
described by Marsh and Watts [26]. The spin-labels were stored at −20 °C in Chl/MeOH
(2/1, v/v) solutions at a concentration of 1 mg/ml.
2.2. Peptide synthesis and puriﬁcation
13-residue peptides were synthesized by Fmoc chemistry, as described elsewhere
[24,27], taking the sequence of porcine SP-C as a template. The peptide named pSP-C
(free) (NH2-L-R-I-P-C-C-P-V-N-L-K-R-L-CONH2), has the two cysteines of the native
sequence in free sulfhydryl form. The other peptide, named pSP-C(Palm)2 (NH2-L-R-I-P-
CPalm-CPalm-P-V-N-L-K-R-L-CONH2) is palmitoylated at Cys5 and Cys6, as in the N-
terminal segment of native SP-C. Both synthetic products were puriﬁed to N95% (HPLC)
homogeneity by semipreparative HPLC on C8-silica linear acetonitrile–water gradients
[24,27]. The puriﬁed materials had the correct amino acid analysis and gave the
expected molecular mass by MALDI-TOF mass spectrometry.
2.3. Lipid/peptide samples
As a membrane model, lipid and lipid/peptide bilayers were prepared using either
DPPC or DPPG as a host phospholipid matrix. These species have been widely used as
models of pulmonary surfactant. DPPC is the main phospholipid species in surfactant
and also that providing the main surface activity [6,28]. Phosphatidylglycerol (PG) is the
main anionic phospholipid in surfactant, bearing also a fair proportion of saturated acyl
chains. Although pulmonary surfactant also contains a substantial proportion of
unsaturated phospholipids, it has been found that saturated PC and PG species se-
gregate in surfactant membranes and ﬁlms [29–31]. Pure DPPC or DPPG bilayers show
well-deﬁned thermotropic behaviour, including sharp temperature-driven gel-to-ﬂuid
phase transitions, which allow direct determination of the effect of proteins and
peptides on both gel and ﬂuid membrane phases. For ESR experiments, appropriate
amounts of DPPC or DPPG and the selected spin-labelled lipid (1 mol%) were dissolved
in Chl/MeOH (2/1, v/v), and mixed with the desired amount of peptide. Organic solvent
was then removed, ﬁrst under a N2 stream, and later by placing the samples under
vacuum overnight. Multilamellar suspensions were prepared by hydrating the samples
in 100 μl of buffer (50 mM HEPES, 150 mM NaCl, pH 7), and the reconstituted material
Fig. 2. Temperature dependenceof the outer splitting, 2Amax, of the ESR spectra of a 5-PCSL
probe inDPPCmembranes (left panel) or a5-PGSLprobe inDPPGmembranes (rightpanel),
in the absence (●) or in the presence of 40wt%of the acylatedpeptide pSP-C(Palm)2 (○), or
the non-acylated peptide pSP-C(free) (▼).
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3000 rpm in a bench centrifuge. In some experiments, the lipid and lipid/protein
complexes were suspended in buffer at different pH values.
2.4. ESR spectroscopy
ESR spectra of lipid and lipid/peptide samples were recorded on a Varian E-12
Century Line 9-GHz spectrometer equipped with a nitrogen gas-ﬂow temperature
regulation system. The sealed capillaries (1-mm outer diameter) were placed in a quartz
tube containing light silicone oil for thermal stability. Temperaturewasmeasuredwith a
ﬁne-wire thermocouple positioned in the silicone oil at the top of the microwave cavity.
Spectra were collected digitally on a personal computer with Labmaster interface.
Instrumental settings were as follows: 10 mW microwave power, 1.25 G modulation
amplitude, 100 kHz modulation frequency, 0.25 s time constant, 4 min scan time, and
100 G scan range. Several scans, typically 3–5, were accumulated to improve the signal-
to-noise ratio. See Perez-Gil et al. (1995) [32] for details of spectral analysis. Figures
represent illustrative data after repeating the experiments with three independently-
synthesized batches of peptides, which showed similar qualitative behavior and
comparable quantitative hyperﬁne splittings.
3. Results
3.1. Temperature dependence
Fig. 1 shows the temperature dependence of the ESR spectra of
5-PCSL spin-labelled phosphatidylcholine in membranes of dipal-
mitoylphosphatidylcholine (DPPC) in the presence and absence ofFig. 3. ESR spectra of different n-PCSL spin-label isomers in DPPC membranes, in the presen
(Palm)2, at 25 °C in the gel phase (left) or at 45 °C in the ﬂuid phase (right). Total scan rang40 wt% of the non-palmitoylated, pSP-C(free), or the dipalmitoy-
lated N-terminal SP-C peptide, pSP-C(Palm)2. For comparison,
details of the low-ﬁeld and high-ﬁeld spectral lines of 5-PCSL, in
the presence and absence of the two peptide sequences, have also
been included in the ﬁgure. All the spectra show, in the absence
(dashed lines) and in the presence (solid lines) of peptide, a
pronounced temperature dependence that is characterized by an
abrupt narrowing of the spectral extent at the chain-melting tran-
sition, around 41 °C. Differences are detected between the spectra
from membranes with and without either peptide, both in the gel
and ﬂuid bilayer phases. The left panel of Fig. 2 illustrates the tem-
perature dependence of the outer hyperﬁne splitting, 2Amax, from
the spectra of 5-PCSL in DPPC membranes in the presence of the
palmitoylated peptide pSP-C(Palm)2, or of the non-acylated peptide
pSP-C(free), both at 40 wt%, relative to DPPC alone. The sharp
chain-melting transition at 40–41 °C is preserved in the presence of
40 wt% peptide. Increases in 2Amax are induced by both peptides in
the gel and ﬂuid phases, however, and the largest difference is
found in the intermediate gel phase, above the pretransition at ca.
30 °C. The palmitoylated peptide essentially abolishes the DPPC
pretransition, removing the cooperative decrease in 2Amax that
takes place on transition from the Lβ′ gel phase to the intermediate
Pβ′ phase of DPPC bilayers. The effect of the non-acylated peptide on
the shallow regions of the membranes sensed by the 5-PCSL probe,
at temperatures above the pretransition, is in the same direction as
that induced by the palmitoylated peptide, but is considerably
weaker.
Somewhat similar results are found on the interaction of both
peptides with DPPG membranes, except that the effect of the non-
acylated peptide is relatively greater. The right-hand panel of Fig. 2
gives the temperature dependence of the outer hyperﬁne splitting of a
5-PGSL spin-label in dipalmitoyl phosphatidylglycerol membranes,
with or without the palmitoylated or non-acylated peptide. In the
presence of either peptide, the pretransition at about 30 °C is prac-
tically completely abolished and a very sharp transition between 40
and 41 °C can be observed. This effect can be explained by the stronger
electrostatic interaction of the cationic peptide with the anionic head-
groups of the DPPG membrane. Inclusion of the non-acylated peptide
in DPPG membranes shifts the transition to temperatures 2–3 °C
higher, corresponding to an electrostatic neutralisation of the surface
charge [33].ce (solid line) or in the absence (dashed line) of 40 wt% of the acylated peptide pSP-C
e of the spectra, 100 G.
Fig. 4. Right: ESR spectra of a 12-PCSL probe in gel-phase DPPC bilayers at 25 °C, in the absence (dotted line) or in the presence of increasing proportions (light grey to black lines
indicate 2, 5, 10, 20 or 40 wt%) of peptide pSP-C(Palm)2. Left panels: outer hyperﬁne splitting, 2Amax (upper), and low-ﬁeld line width at half-height, ΔHl (lower), as a function of
peptide/lipid ratio in the membranes.
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Fig. 3 shows the ESR spectra of n-PCSL phosphatidylcholines spin-
labelled at different positions, n, of the sn-2 chain in DPPCmembranes,
with and without dipalmitoylated peptide. The left-hand panel refers
to membranes in the gel phase at 25 °C and the right-hand panel to
membranes in the ﬂuid phase at 45 °C. A uniformly small perturbation
inmobility by the peptide is seen throughout the ﬂuid phase. In the gel
phase, however, the perturbation by the acylated peptide is greatest
towards the terminal methyl end of the chain, where the mobility in a
non-interdigitated DPPC gel phase is appreciable (see e.g. [34]). Addi-Fig. 5. Positional (n) dependence of the outer splitting, 2Amax, in the ESR spectra of n-PCSL spin
membranes (right side), in the absence (●) or in the presence of 40wt% palmitoylated peptide
panels) or 45 °C (ﬂuid phase; lower panels).tionally, for label positions in the middle of the chain, n=8–12, the
spin–spin broadening that is evident in the gel phase of the DPPC alone
[35] is removed in the presence of 40wt% of the palmitoylated peptide.
This effect on the chain packing of gel-phase lipids is a feature that the
N-terminal peptide shares in common with native SP-C [32]. Fig. 4
(right) shows that exclusion of the 12-PCSL spin probe from the gel
phase of DPPC at 25 °C is substantially reduced already by the addition
of 1 wt% of pSP-C(Palm)2. The dependence of the effective hyperﬁne
splitting, 2Amax, and low-ﬁeld linewidth, ΔHl, on peptide content (see
Fig. 4, left) demonstrates that the peptide–lipid interaction is close to
saturation at 40 wt% pSP-C(Palm)2. The non-palmitoylated sequence-label isomers in DPPCmembranes (left side), and of n-PGSL spin-label isomers in DPPG
pSP-C(Palm)2 (○) or the non-acylated peptide pSP-C(free) (▼), at 25 °C (gel phase; upper
Fig. 6. ESR spectra of different n-PCSL spin-label isomers in DPPC membranes at 37 °C, in the absence (dotted lines) or in the presence (solid lines) of 40 wt% of the palmitoylated
peptide pSP-C(Palm)2 (left column) or the non-acylated peptide pSP-C(free) (right column). Total scan width: 100 G. Arrows indicate the position of the immobilized spectral
component that is attributed to a lipid population in an interdigitated (Lβi ) phase.
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the spin probe in the gel phase (not shown).
Fig. 5 (lower left-hand panel) shows the dependence of the n-PCSL
outer hyperﬁne splitting, 2Amax, on position, n, of chain spin-
labelling for ﬂuid DPPC bilayers, in the presence and absence of the
dipalmitoylated or non-acylated peptide. The chain ﬂexibility proﬁle
with increasing n, which is characteristic of spin-labelled lipid chains
in ﬂuid phase membranes, is preserved in the presence of both pep-
tides. Only modest increases in 2Amax are found at any chain position
in the ﬂuid phase. In the gel phase at 25 °C, both peptides perturb the
mobility proﬁle, in the sense that the values of Amax for n=14 become
more comparable to those for n=5, in the presence of peptide (see
Fig. 5, upper left). This removal of the mobility gradient is a feature
associated with the formation of an interdigitated gel phase, Lβi , in
DPPC bilayers (see e.g. [34,36]). The right-hand panels of Fig. 5 give the
positional dependences of the outer hyperﬁne splittings of the n-PGSL
spin-labels in gel and ﬂuid DPPG membranes, with and without the
palmitoylated or non-acylated peptides. Overall, much the same
differential features are exhibited in the interaction of the two pep-
tides as with membranes of DPPC, except that the perturbations of
DPPGmembranes by the peptides are considerably larger, particularly
in the ﬂuid phase. As already mentioned above, it is possible that in
the absence of palmitoylation the electrostatic interactions between
the cationic peptide and the anionic phospholipid headgroups domi-
nate and cause the peptide to interact differently with anionic bi-
layers, as compared with zwitterionic bilayers.
3.3. Phase coexistence
Fig. 6 shows the ESR spectra of different n-PCSL spin-labelled
positional isomers in DPPC membranes at 37 °C, i.e., corresponding to
the intermediate Pβ′ phase in the absence of peptide. A notable featureTable 1
Outer hyperﬁne splittings, in the presence and absence of peptide pSP-C(Palm)2 or pSP-
C(free), of phosphatidylcholine spin-labelled at the 14th or 16th position of the sn-2
acyl chain, incorporated in DPPC bilayers at 37 °C
2Amax (gauss)
DPPC DPPC/pSP-C(free) DPPC/pSP-C(palm)
14-PCSL 33.8 48.3 59.6, 34.2
16-PCSL 32.3 32.7 43.3, 32.5is the coexistence of two spectral components for spin-labels situated
towards the terminal methyl position (i.e., at n=14–16), in the
presence of the palmitoylated peptide, pSP-C(Palm)2. This suggests
that, at 37 °C, the membranes containing the dipalmitoylated peptide
are in a state of coexistence between interdigitated and non-
interdigitated gel phases, because the outer spectral component that
is characteristic of the Lβi -phase is more strongly immobilised (2Amax
~60 G for 14-PCSL, see Table 1) than in the peptide-free Pβ′-phaseFig. 7. ESR spectra of a 14-PCSL spin probe in DPPC membranes at 37 °C in the presence
of increasing amounts (wt%) of the palmitoylated peptide pSP-C(Palm)2. For
comparison, the ESR spectrum of membranes containing 40 wt% of the non-
palmitoylated peptide is also included (dotted line). Total scan width: 100 G. Arrows
indicate the position of a second, more immobilized, spectral component. Inset: ratio of
low-ﬁeld lineheights of the immobilized relative to the non-immobilized component,
with the latter normalized with respect to the peak-to-peak linewidth squared, versus
the peptide to lipid ratio.
Table 2
Differences in the outer hyperﬁne splittings, in the presence and absence of peptide
pSP-C(Palm)2 or pSP-C(free), of different phospholipid species spin-labelled at the ﬁfth
position of the sn-2 acyl chain, incorporated in DPPC bilayers at 45 °C
2ΔAmax (gauss) 2ΔΔAmax a (gauss)
pSP-C(free) pSP-C(palm) pSP-C(free) pSP-C(palm) SP-C b
5-PCSL 0.2 1 0 0 0
5-PESL 0.1 0.8 −0.1 −0.2 −0.4
5-PGSL 0.1 0.7 −0.1 −0.25 −0.4
5-SMSL 0.3 0.7 0.1 −0.3
5-PASL pH 8.5 0.9 0.7 0.8 −0.3
5-PSSL 0 0.1 −0.2 −0.8 −0.5
5-SASL pH 8.5 0 0 −0.2 −1 −1.4
a 2ΔΔAmax=2ΔAmax−2ΔAmax (5-PCSL).
b Native, full-length SP-C. Data from ref. [32].
Fig. 8. ESR spectra of 5-SASL, a free fatty acid spin probe, in DPPC membranes at the pH
values indicated, at 45 °C, in the absence or in the presence of the palmitoylated peptide
pSP-C(Palm)2 or the non-acylated peptide pSP-C(free). Total scan width: 100 G. The
positions of the outer hyperﬁne peaks in the low- and high-ﬁeld regions of the spectra
are indicated by vertical lines.
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components is indicated at other positions of spin-labelling in the
left-hand part of Fig. 6. It is manifested by a shoulder on the low-ﬁeld
peak in the spectra of 8-, 10- and 12-PCSL. Also, two components are
clearly resolved in the spectra of 5-PCSL in the pretransition region at
38–40 °C for DPPC samples containing 40 wt% palmitoylated peptide
(solid lines in Fig. 1). Note that, although the spectral anisotropy of 14-
PCSL is increased by the non-palmitoylated peptide, pSP-C(free), the
outer hyperﬁne splitting (2Amax ~50 G) still remains considerably
smaller than that for an interdigitated gel phase.
Fig. 7 shows the dependence of the two-component spectra of 14-
PCSL at 37 °C on the content of palmitoylated peptide in DPPC
membranes. The relative intensity of the outer, motionally restricted,
spectral component increases progressively with increasing peptide
content, while its lineshape remains unchanged beyond 10 wt% with
2Amax ~60 G. This suggests strongly that at 37 °C the palmitoylated
peptide is preferentially associated with domains of interdigitated
lipid, the formation of which is driven by the lipid–peptide inter-
action. As the content of palmitoylated peptide in the membrane
increases, either the size or number of the interdigitated domains
increases. This is a property that is associated predominantly with the
palmitoylated peptide. The spectrum of 14-PCSL in the presence of the
non-acylated peptide shows much less contribution of immobilized
components, which cannot be clearly resolved. The palmitoyl chains
attached to the peptide therefore must potentiate formation of an
interdigitated gel phase. The insert in Fig. 7 shows how the proportion
of the more immobilized component titrates with increasing peptide/
lipid ratio, as followed by the spectral lineheight of the immobilized
(interdigitated-like) component, relative to that of the less immobi-
lized (non-interdigitated) component.
3.4. Phospholipid selectivity
To evaluate potential selectivity of the N-terminal segment of SP-C
in the interaction with different phospholipid classes, the ESR spectra
of different phospholipid species spin-labelled at the ﬁfth position of
the sn-2 chain were recorded in DPPC bilayers, in the presence or
absence of peptide [37]. Spin probes tested include phosphatidylcho-
line (5-PCSL), phosphatidylethanolamine (5-PESL), phosphatidylgly-
cerol (5-PGSL), sphingomyelin (5-SMSL), phosphatidic acid (5-SASL),
phosphatidylserine (5-PSSL) and stearic acid (5-SASL). Spectra of 5-
PASL and 5-SASL were obtained at pH 8.5, to avoid the overlapping of
components arising from protonated and deprotonated species which
coexist at lower pH values. Either peptide was added at 40 wt% and
measurements were made at a ﬁxed temperature of 45 °C in the ﬂuid
phase, to ensure miscibility of host lipids and probes.
Table 2 gives the increase in the outer hyperﬁne splitting, 2ΔAmax,
of each spin probe due to the presence of the corresponding peptide,
with respect to the same probe in pure lipid bilayers. 2ΔΔAmax is thedifference between 2ΔAmax calculated for each lipid probe and that
obtained using the 5-PCSL phosphatidylcholine spin-label. For
comparison, data on 2ΔΔAmax obtained previously with full-length
native porcine SP-C [32] are also included in the Table. In general
terms, the palmitoylated peptide produced higher values of 2ΔAmax
than those caused by the non-acylated peptide, conﬁrming the greater
ability of the palmitoylated sequence to perturb and immobilize
phospholipid acyl chains in bilayers. Interestingly, pSP-C(free) shows
very small values of 2ΔAmax for all spin-labelled lipids except for the
interaction with the dianionic phospholipid 5-PASL, pointing again to
a greater electrostatic effect with the non-acylated peptide. The
absolute values of 2ΔAmax produced by the full-length SP-C molecule
[32] are much larger than those produced by the N-terminal
palmitoylated segment, indicating that most of the immobilizing
effect of the wild-type protein is mediated by the hydrophobic
transmembrane segment. However, the selectivities relative to
phosphatidylcholine, which are given by the values of 2ΔΔAmax in
Table 2, are comparable for full-length protein and palmitoylated
peptide. This suggests that the limited lipid selectivity that is
exhibited by SP-C resides in the palmitoylated N-terminal segment.
3.5. Effect on pKs at the membrane surface
In order to determine the inﬂuence of the SP-C N-terminal peptide
on the polarity of the membrane surface, we studied the effect of
acylated and non-acylated peptides on the ionization properties of a
stearic-acid spin probe. This was detected by pH-dependent spectral
changes related to differences in mobility of the protonated and
deprotonated species under different pH conditions (see [38]). A shift
in pKa of the stearic acid carboxyl group in the presence of the peptide
could arise from a change in polarity in the region of the lipid
headgroups, an electrostatic contribution of the peptide charge, and/
or the energetics of lipid–protein interaction [38,39]. Fig. 8 shows the
spectra of a 5-SASL stearic-acid spin probe in DPPC bilayers at 45 °C, at
different pH values. At pH 5.5, the reduced hyperﬁne anisotropy
indicates the relatively high mobility of the fully protonated stearic
acid in ﬂuid DPPC bilayers. On the other hand, at pH 8.5, the spectral
anisotropy increases because of the higher orientational ordering of
the anionic form of the fatty acid, which is more ﬁrmly anchored at the
membrane surface [40,41]. At pH 7, in the absence of peptides, both
charged and uncharged forms of stearic acid coexist, as seen from the
two overlapping spectral components. This indicates that pH 7 is close
Fig. 9. a) Cartoon illustrating the conﬁguration of a peptide-promoted interdigitated structure in phospholipid bilayers. b) Model for the possible participation of an SP-C-promoted
interdigitated intermediate in facilitating transfer of phospholipids to the air–liquid interface, and in the compression-driven formation of surface-associated surfactant structures.
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reported previously [32]. The spectra of the stearic acid probe in the
presence of the peptides show that the palmitoylated peptide, but not
the non-palmitoylated peptide, shifts the ionization equilibrium of the
fatty acid to lower pH. In the presence of pSP-C(Palm)2, 5-SASL gives a
spectrum at pH 7, which has an outer hyperﬁne splitting comparable
to that obtained at pH 8.5 in the absence of peptide. Hence the fatty
acid is fully deprotonated at pH 7 in the presence of pSP-C(Palm)2,
whereas the protonation state at pH 7 remains essentially unchanged
in the presence of the non-acylated pSP-C(free) peptide. Interaction
with the palmitoylated N-terminal segment, but not with the non-
palmitoylated peptide, therefore increases the polarity of the
membrane surface, which gives rise to a decrease in interfacial pKa
of stearic acid. (Note that the pKa of stearic acid in aqueous solution is
about 5.0). In this sense, the palmitoylated N-terminal segment of SP-
C is mimicking the effect of the whole protein, which is also able to
increase the apparent polarity of the bilayer surface, as monitored by
the pH titration of SASL probes [32]. Such an effect cannot be
attributed purely to the accumulation of surface charge, because the
non-palmitoylated SP-C peptide possesses an identical cationic charge
but does not produce equivalent pK shifts. The different effect that
pSP-C(palm)2 exerts compared with pSP-C(free) underlines the role of
acylation in modulating the way that the N-terminal segment of SP-C
interacts with the surface of phospholipid layers.
4. Discussion
The data provided by the present study show how palmitoylation
of two adjacent cysteine residues in the N-terminal segment of SP-C
affects its interaction with phospholipid bilayers. It has been reported
that the presence of palmitic chains can be important for modulating
the conformation of the N-terminal segment, and may also inﬂuence
the structure of the remainder of the protein. Absence of the acyl
chains has been related directly to transformation of the α-helical
structure of SP-C into β-sheet conformers, leading to formation of SP-C
aggregates and amyloid-like ﬁbril structures [11,12]. Both IR spectro-
scopy [24] and CD spectroscopy (data not shown) show a higher
proportion of α-helical structure in the palmitoylated peptide than in
the non-palmitoylated peptide. Hence, differences in the conforma-
tional state of this region could be responsible in part for differences in
lipid–protein and/or protein–protein interactions with the acylated
and non-acylated N-terminal sequences.Under physiological conditions, the native form of SP-C is
palmitoylated and is closely associated with surfactant phospholipid
membranes.Wehave shown recently that the primary sequence of this
region of SP-C has an amphipathic character [27], including an intrinsic
tendency to associate with phospholipid membranes [22] and inter-
facial ﬁlms [23]. Palmitoylation, therefore, is not strictly required for
primary membrane association, making it important to investigate
whether this postranslationalmodiﬁcation has other speciﬁc functions
that are of potential relevance to pulmonary surfactant physiology.We
have proposed that the N-terminal segment of SP-C forms an
amphipathic hairpin, including a central hydrophobic β-turn that
becomes even more hydrophobic upon acylation, ﬂanked by two
cationic loci [27]. The data from the present study show that bilayer
insertion of this putative hydrophobic hairpin results in formation of
an interdigitated-like lipid phase. In such structures, as illustrated by
the cartoon in Fig. 9a, the central hydrophobic part of the hairpin could
establish direct interactions with distal segments of the phospholipid
acyl chains while the polar residues of the peptide hairpin could still
interact with the lipid headgroups. This model would be consistent
with the effect of the peptides on the chain ﬂexibility proﬁle of both
DPPC and DPPG bilayers at temperatures below their main transition.
In a previous study, we reported the effect on membranes of a
peptide designed from the N-terminal segment of SP-C but having two
cysteines blocked by acetamidomethyl groups [22]. From the data
available at the time we assumed that this peptide was a good mimic
for the N-terminal segment of SP-C. The blocked N-terminal analog
showed a strong perturbation of the ﬂuid phase of DPPC and DPPG
bilayers, without promoting interdigitated-like phases such as those
described here. The present study now shows that the peptides with
free or palmitoylated cysteines, unlike that with the spurious
acetamidomethyl group, are well suited to intercalate within
ordered-like lipids such as those potentially taking part in the Pβ′
phase. This feature is probably required to promote formation of
interdigitated lipid regions. Fig. 5 shows maximal immobilization
effects of the peptides around positions 5 and 14 of the phospholipid
acyl chains, which is characteristic of an interdigitated gel phase
[33,35].
Intercalation of palmitic chains attached to theN-terminal peptides
could stabilize the interdigitated structure, resulting in the appearance
of an increasing population of interdigitated lipids with increasing
peptide/lipid ratio (seen in Figs. 6 and 7). Intercalation of peptide and
phospholipid molecules to form interdigitated structures could then
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chains up to temperatures close to the main gel-to-ﬂuid phase
transition. Interestingly, a recent study has proposed that the Pβ′ ripple
phase might consist of a coexistence of bilayered and interdigitated
lipid phases [42]. Palmitoylation could thenpromote stable association
of the N-terminal segment with interdigitated patches that might
already exist in the ripple phase and promote their spatial extension.
This property could be important to ensure maximal stability of DPPC-
enriched domains segregated in pulmonary surfactant ﬁlms at physio-
logical temperatures [30,31]. These domains might have order and
packing properties similar to those exhibited by DPPC bilayers at 37 °C,
the temperature at which stabilization of interdigitated-like mem-
brane regions by the N-terminal segment seems to be maximal. In one
of the few studies published so far on lipid–protein interactions of
acylated peptides, a speciﬁc effect of an acylated peptide on the Pβ′
ripple phase of DPPC bilayers has also been reported [43], suggesting
that association with and possible stabilization of interdigitated-like
regions could be a general feature favoured by palmitoylated segments
of proteins. In the pure Lα phase, the lipid chains are too disordered to
allow organization of well-deﬁned interdigitated structures, and the
peptides are then associated with normal bilayer structures.
Protein-attached saturated palmitic chains are particularly well
suited to insert into ordered membrane structures, such as the inter-
digitated structures proposed here, the condensed interfacial phases
reached at the end of expiration, and the liquid-ordered regions
adopted by raft-likemembrane domains enriched in sphingolipids and
cholesterol. Several examples have been reported in the literature
showing that palmitoylation may promote association of certain
proteins with ordered membrane domains [44–47]. Our results also
suggest that palmitoylated protein segments could contribute to
nucleate ordered membrane regions, the size and stability of which
still remains to be evaluated. We have observed similar qualitative
effects in samples containing peptides over the whole range 1–40%
protein/lipid (w/w). This includes the peptide-induced increase in
2Amax, the reduction of spin–spin broadening, and the segregation of
an immobilized lipid component (see ESR spectra at different peptide/
lipid ratios in Figs. 4 and 7). No discontinuities were detected in the
progressive effects caused by increasing peptide contents, which could
have been indicative of phase transformation, e.g., micellisation in the
membranes at the highest peptide/lipid ratios.
The cartoon in Fig. 9b illustrates the possible participation of the
lipid/protein structures that are promoted by the palmitoylated N-
terminal segment of SP-C in the activities of pulmonary surfactant at
the respiratory air–liquid interface. SP-C promotes transfer of
phospholipids from phospholipid bilayers to the air–liquid interface
[11,18], independent of its acylation state. Simultaneous perturbation
of membranes [22] and monolayers [23] by the N-terminal segment
of SP-C could permit transient exposure of phospholipid molecules,
hence accelerating interfacial adsorption. An SP-C-promoted transi-
tion of surfactant structures from non-interdigitated to interdigi-
tated bilayer-like arrangements, initiated at locations where SP-C is
accumulated [29,48,49], might accelerate bilayer/monolayer conver-
sions. On the other hand, compression of SP-C-containing interfacial
lipid–protein ﬁlms could induce a progressive accumulation of SP-C
in deﬁned locations of the surface layers [48,50]. Sufﬁciently high
protein density could favour formation of an ordered lipid/protein
phase, where the palmitic chains of the N-terminal segment of SP-C
could be intercalated with the phospholipid chains, in a manner
similar to the interdigitated structure proposed here. These surface
structures could be particularly favourable for initiating transitions
that fold the interfacial ﬁlm towards the bulk phase, and so induce
formation of the surface-associated multilayered structures that are
known to be promoted by SP-C [25,51]. Such multilayered structures
associated with surfactant interfacial ﬁlms have been demonstrated
in recent years [52,53], and are now a central part of current mole-
cular models of pulmonary surfactant action [54]. Surface-associatedsurfactant reservoirs would have the dual role of improving mechan-
ical stability of highly compressed ﬁlms at the end of expiration, and
of promoting replenishment of the surface ﬁlm with new surfactant
molecules that are inserted into the interface during inspiration.
Palmitoylation could prevent total dissociation of the multilayered
structures from the highly packed interfacial ﬁlm [24]. This possi-
bility could explain why surfactant obtained from SP-C knock-out
mice forms intrinsically unstable ﬁlms [3], which could be respon-
sible at least in part for the development of chronic respiratory
problems in animals and patients whose lungs lack SP-C [4]. The
ability of the SP-C N-terminal segment to maintain association with
highly compressed ﬁlms would be especially important at the end
of exhalation, when the highest surface pressures (lowest surface
tensions) must be supported.
Nevertheless, it is important to consider that the nature of the
structures promoted by SP-C and its N-terminal segment in surfactant
complexes that are reconstituted in vitro from lipid/protein or lipid/
peptide organic solutionsmay differ from the structure and disposition
of surfactant structures that are assembled in vivo into the lamellar
bodies of pneumocytes. Very little is known about the orientation of
SP-C in the membrane structures reaching the pulmonary interface.
It is possible that SP-C-promoted membrane perturbations when the
N-terminal segment has access to both sides of the membrane – as
presumably occurs in complexes reconstituted in vitro – could differ
from those when SP-C perturbs the membranes from a single side,
either alone or in concert with other surfactant proteins. Further
studies with native surfactant complexes are still required before
we shall be able to model fully functional pulmonary surfactant
complexes.
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